A randomised comparison between everolimus-eluting stent and sirolimus-eluting stent in chronic coronary total occlusions. Rationale and design of the CIBELES (non-acute Coronary occlusion treated by EveroLimus-Eluting Stent) trial

EuroIntervention

Volumn 6, Issue 1, 2010, Pages 112-116

  Moreno, Raúl ^a   Garcia, Eulogio ^b   Teles, Rui C ^c   Almeida, Manuel S ^c   Carvalho, Henrique Cyrne ^d   Sabate, Manel ^e   Martin Reyes, Roberto ^a   Rumoroso, José Ramón ^f   Galeote, Guillermo ^a   Goicolea, Francisco Javier ^g   Moreu, José ^h   Mainar, Vicente ⁱ   Mauri, Josefa ^j   Ferreira, Rui ^k   Valdes, Mariano ^l   Perez De Prado, Armando ^m   Martin Yuste, Victoria ^m   Jimenez Valero, Santiago ^a   Sanchez Recalde, Angel ^a   Calvo, Luis ^a   Lopez De Sa, Esteban ^a   Macaya, Carlos ^b   Lopez Sendon, Jose Luis ^a   more..

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^c Hospital Sta Cruz ^*  (Portugal)

^d HOSPITAL DE SANTO ANTÓNIO   (Portugal)

^e HOSPITAL CLÍNIC   (Spain)

^f HOSPITAL DE GALDAKAO   (Spain)

^g HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^h HOSPITAL VIRGEN DE LA SALUD   (Spain)

ⁱ HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^j HOSPITAL DE SANTA MARIA   (Portugal)

^k HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^l Complejo Hospitalario de Leon ^*  (Spain)

^m HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

more..

Author keywords

Chronic coronary occlusion; Clinical trial; Coronary stent

Indexed keywords

ACETYLSALICYLIC ACID; CYPHER; EVEROLIMUS; PACLITAXEL; RAPAMYCIN; THIENOPYRIDINE DERIVATIVE; UNCLASSIFIED DRUG; CARDIOVASCULAR AGENT; DRUG DERIVATIVE;

ADULT; ANGIOGRAPHY; ARTERIOVENOUS FISTULA; ARTICLE; BARE METAL STENT; BLEEDING; CONTROLLED STUDY; CORONARY STENT; DEATH; DRUG ACTIVITY; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG ELUTING STENT; FALSE ANEURYSM; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HIGH RISK PATIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PORTUGAL; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; RETROPERITONEAL HEMORRHAGE; SINGLE BLIND PROCEDURE; SPAIN; STENT THROMBOSIS; VASCULAR DISEASE; ANGIOCARDIOGRAPHY; CHRONIC DISEASE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; INSTRUMENTATION; METHODOLOGY; PROSTHESIS; RADIOGRAPHY; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIOVASCULAR AGENTS; CHRONIC DISEASE; CORONARY ANGIOGRAPHY; CORONARY OCCLUSION; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; HUMANS; PORTUGAL; PROSTHESIS DESIGN; RESEARCH DESIGN; SINGLE-BLIND METHOD; SIROLIMUS; SPAIN; TIME FACTORS; TREATMENT OUTCOME;

EID: 77957256967     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV6I1A17     Document Type: Article

References (17)

1. Bavry AA, Bhatt DL. Appropriate use of drug-eluting stents: balancing the reduction in restenosis with the concern of late thrombosis. Lancet 2008;371:2134-2143. (Pubitemid 351842583)
2. Moreno R, Fernandez C, Sanchez-Recalde A, Galeote G, Calvo L, Alfonso F, Hernandez R, Sánchez-Aquino R, Angiolillo DJ, Villarreal S, Macaya C, Lopez-Sendon JL. Clinical impact of in-stent late loss after drug-eluting coronary stent implantation. Eur Heart J. 2007;28:1583-91. (Pubitemid 47227108)
3. Di Mario C, Werner GS, Sianos G, Galassi AR, Büttner J, Dudeck D, Chevalier B, Lefevre T, Schofer J, Koolen J, Sievert H, Reimers B, Fajadet J, Colombo A, Gershlick A, Serruys PW, Reifart N. European perspective on the recanalisation of chronic total occlusions (CTO): consensus document from the Euro-CTO club. EuroIntervention 2007;3:30-43.
4. Rubartelli P, Niccoli L, Verna E, Giachero C, Zimarino M, Fontanelli A, Vassanelli C, Campolo L, Martuscelli E, Tommasini G. Stent implantation versus balloon angioplasty in chronic coronary occlusions: results from the GISSOC trial. J Am Coll Cardiol 1998;32:90-96. (Pubitemid 28351047)
5. Suttorp MJ, Laarman GJ, Rahel BM, Kelder JC, Bosschaert MA, Kiemeneij F, Ten Berg JM, Bal ET, Rensing BJ, Eefting FD, Mast EG.. Primary Stenting of Totally Occluded Native Coronary Arteries II (PRISON II): a randomized comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions. Circulation 2006;114:921-8.
6. Werner GS, Krack A, Schwarz G, Prochnau D, Betge S, Figulla HR. Prevention of lesion recurrence in chronic total coronary occlusions by paclitaxel-eluting stents. J Am Coll Cardiol. 2004;44:2301-6. (Pubitemid 39647602)
7. Jang JS, Hong MK, Lee CW, Park DW, Lee BK, Kim YH, Han KH, Kim JJ, Park SW, Park SJ. Comparison between sirolimus- and paclitaxel- eluting stents for the treatment of chronic total occlusions. J Invasive Cardiol. 2006;18:205-8. (Pubitemid 44576070)
8. Tsuchiya F, Lansky AJ, Costa RA, Mehran R, Pietras C, Shimada Y, Sonoda S, Cristea E, Negoita M, Dangas GD, Moses JW, Leon MB, Fitzgerald PJ, Müller R, Störger H, Hauptmann KE, Grube E. Effect of Everolimus-Eluting Stents in Different Vessel Sizes (from the Pooled FUTURE I and II Trials). Am J Cardiol 2006;98:464-469. (Pubitemid 44177577)
9. Tsuchida A, K, Piek JJ, Neumann FJ, van der Giessen WJ, Wiemer M, Zeiher AM, Grube E, Haase J, Thuesen L, Hamm CW, Veldhof S, Dorange C, Serruys PW.. One-year results of a durable polymer everolimus-eluting stent in de novo coronary narrowings (The SPIRIT FIRST trial). EuroIntervention 2005;1:266-72.
10. Ruygrok PN, Desaga M, Van Der Branden F, Rasmussen K, Suryapranata H, Dorange C, Veldhof S, Serruys PW, on behalf of the SPIRIT II Investigators. One year clinical follow-up of the XIENCE V Everolimus-eluting stent system in the treatment of patients with de novo native coronary artery lesions: the SPIRIT II study. EuroIntervention 2007;3:315-320.
11. Stone GW, Midei M, Newman W, Sanz M, Hermiller JB, Williams J, Farhat N, Mahaffey KW, Cutlip DE, Fitzgerald PJ, Sood P, Su X, Lansky AJ; the SPIRIT III Investigators. Comparison of an Everolimus-Eluting Stent and a Paclitaxel-Eluting Stent in Patients With Coronary Artery Disease. A Randomized Trial. JAMA. 2008;299:1903-1913.
12. Stone G, for the SPIRIT-IV investigators. SPIRIT IV. A prospective, randomized trial comparing everolimus-eluting stent and paclitaxel-eluting stent in patients with coronary artery disease. One year results. Available at: http://www.tctmd.com/show.aspx?id=84104. Accessed February 3rd 2010.
13. Kedhi E, Joesoef KS, McFadden E, Wassing J, van Mieghem C, Goedhart D, Smits PC. Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial. Lancet. 2010 Jan 16;375(9710):201-9.
14. Biondi-Zoccai G, Lotrionte M, Moretti C, Agostoni P, Sillano D, Laudito A, Sheiban I. Percutaneous coronary intervention with everolimus-eluting stents (Xience V): systematic review and direct-indirect comparison meta-analyses with paclitaxel-eluting stents (Taxus) and sirolimus-eluting stents (Cypher). Minerva Cardioangiol 2008;56:55-65.
15. Moreno R, Martin-Reyes R, Jimenez-Valero S, Sanchez-Recalde A, Galeote G, Sabate M, Plaza l, Lopez-Sendon JL. Peri-procedural (30 days) risk of myocardial infarction after drug-eluting coronary stent implantation. A meta-analysis comparing cobalt-chromium and stainless-steel drug-eluting coronary stents. EuroIntervention. in press
16. Nakamura S, Nakamura S, Ogawa H, Bae JH, Cahyadi YH, Udayachalerm W, Tresukosol D, Tansuphaswadikul S.. Drug-Eluting Stents for the Treatment of Chronic Total Occlusion: A Comparison with Sirolimus, Paclitaxel, Zotarolimus, EPC Capture and Everolimus-Eluting Stent: Multicenter Registry in Asia (Abstr.). Circulation 2008;118:S737.
17. Vranckx P, Kint PP, Morel MA, Van Es GA, Serruys PW, Cutlip D. Identifying stent thrombosis, a critical appraisal of the Academic Research Consortium (ARC) consensus definitions: a lighthouse and a toe in the water. EuroIntervention 2008;4:C39-C44.